{"id":65663,"date":"2026-05-19T19:55:36","date_gmt":"2026-05-19T11:55:36","guid":{"rendered":"https:\/\/flcube.com\/?p=65663"},"modified":"2026-05-19T19:55:37","modified_gmt":"2026-05-19T11:55:37","slug":"ande-healthcare-files-hong-kong-ipo-prospectus-as-leading-chinese-medical-consumables-innovator","status":"publish","type":"post","link":"https:\/\/flcube.com\/?p=65663","title":{"rendered":"Ande Healthcare Files Hong Kong IPO Prospectus as Leading Chinese Medical Consumables Innovator"},"content":{"rendered":"\n<p><strong>Shandong Ande Healthcare Apparatus Co., Ltd.<\/strong> has <strong>released its prospectus<\/strong> and formally <strong>applied for listing on the Hong Kong Stock Exchange<\/strong>, marking a significant milestone for one of China&#8217;s leading <strong>innovative medical consumables providers<\/strong>. The company offers a <strong>competitive and diversified product portfolio<\/strong> spanning critical healthcare segments including <strong>drug delivery, vascular access, blood specimen collection<\/strong>, and specialized categories encompassing <strong>interventional therapy products, surgical products, and medical imaging consumables<\/strong>.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-business-overview-amp-product-portfolio\">Business Overview &amp; Product Portfolio<\/h2>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><th>Core Segments<\/th><th>Key Product Categories<\/th><\/tr><\/thead><tbody><tr><td><strong>Drug Delivery<\/strong><\/td><td>Advanced infusion systems, precision dosing devices, specialty administration products<\/td><\/tr><tr><td><strong>Vascular Access<\/strong><\/td><td>Peripheral and central venous catheters, safety-engineered access devices, IV connectors<\/td><\/tr><tr><td><strong>Blood Specimen Collection<\/strong><\/td><td>Vacuum blood collection tubes, safety blood collection sets, specimen handling systems<\/td><\/tr><tr><td><strong>Specialized Categories<\/strong><\/td><td><strong>Interventional therapy products<\/strong>, <strong>surgical products<\/strong>, <strong>medical imaging consumables<\/strong><\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-customer-base-amp-market-position\">Customer Base &amp; Market Position<\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Primary Customers<\/strong>: Companies engaged in <strong>pharmaceutical product distribution<\/strong> and <strong>medical device distribution<\/strong><\/li>\n\n\n\n<li><strong>Market Leadership<\/strong>: Positioned as a <strong>leading innovative provider<\/strong> in China&#8217;s medical consumables sector<\/li>\n\n\n\n<li><strong>Distribution Model<\/strong>: B2B-focused approach leveraging established healthcare distribution networks<\/li>\n\n\n\n<li><strong>Geographic Reach<\/strong>: Primarily serves the Chinese market with potential for international expansion post-IPO<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-strategic-rationale-for-hong-kong-listing\">Strategic Rationale for Hong Kong Listing<\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Capital Markets Access<\/strong>: Hong Kong provides attractive valuation multiples for Chinese healthcare companies with strong domestic market positions<\/li>\n\n\n\n<li><strong>International Investor Base<\/strong>: Access to global institutional investors seeking exposure to China&#8217;s growing healthcare consumption<\/li>\n\n\n\n<li><strong>Currency Advantages<\/strong>: HKD listing provides currency stability compared to mainland exchanges<\/li>\n\n\n\n<li><strong>Regulatory Credibility<\/strong>: Hong Kong Exchange listing enhances corporate governance standards and international recognition<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-market-context-amp-industry-dynamics\">Market Context &amp; Industry Dynamics<\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Chinese Medical Consumables Market<\/strong>: Projected to reach <strong>RMB 180 billion<\/strong> ($25 billion) by 2028, growing at 12% CAGR driven by aging population, healthcare infrastructure expansion, and quality upgrade initiatives<\/li>\n\n\n\n<li><strong>Innovation Focus<\/strong>: Regulatory reforms encouraging domestic innovation in medical devices and consumables, reducing reliance on imported products<\/li>\n\n\n\n<li><strong>Supply Chain Localization<\/strong>: Government policies favoring domestic suppliers in public hospital procurement, creating tailwinds for established local players like Ande Healthcare<\/li>\n\n\n\n<li><strong>Post-Pandemic Momentum<\/strong>: Accelerated adoption of advanced medical consumables following pandemic-driven healthcare system upgrades<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-competitive-advantages\">Competitive Advantages<\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Portfolio Diversification<\/strong>: Broad product range reduces dependency on single product categories and provides cross-selling opportunities<\/li>\n\n\n\n<li><strong>Innovation Capability<\/strong>: Focus on &#8220;innovative&#8221; positioning suggests R&amp;D investment and differentiated product offerings<\/li>\n\n\n\n<li><strong>Established Distribution<\/strong>: Strong relationships with pharmaceutical and medical device distributors ensure market access and commercial execution<\/li>\n\n\n\n<li><strong>Domestic Manufacturing<\/strong>: Local production capabilities provide cost advantages and supply chain security in China&#8217;s import-substitution environment<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-ipo-market-conditions\">IPO Market Conditions<\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Healthcare Sector Performance<\/strong>: Hong Kong healthcare IPOs have shown resilience despite broader market volatility, with quality assets commanding premium valuations<\/li>\n\n\n\n<li><strong>Investor Appetite<\/strong>: Strong demand for Chinese healthcare companies with proven domestic market leadership and clear growth trajectories<\/li>\n\n\n\n<li><strong>Valuation Expectations<\/strong>: Analysts anticipate Ande Healthcare could achieve enterprise value of <strong>HK$8-12 billion<\/strong> based on comparable medical consumables companies<\/li>\n<\/ul>\n\n\n\n<p><strong>Forward-Looking Statements<\/strong><br>This brief contains forward-looking statements regarding Ande Healthcare&#8217;s IPO process, market opportunities, and business prospects. Actual results may differ due to risks including regulatory approval timelines, market conditions, competitive dynamics, and execution of business strategy.<a href=\"https:\/\/flcube.com\/\">-Fineline Info &amp; Tech<\/a><\/p>\n\n\n\n<div data-wp-interactive=\"core\/file\" class=\"wp-block-file\"><object data-wp-bind--hidden=\"!state.hasPdfPreview\" hidden class=\"wp-block-file__embed\" data=\"https:\/\/flcube.com\/wp-content\/uploads\/2026\/05\/sehk26051500133_c.pdf\" type=\"application\/pdf\" style=\"width:100%;height:600px\" aria-label=\"Embed of sehk26051500133_c.\"><\/object><a id=\"wp-block-file--media-124fa096-2a2d-4952-ad68-32dc6b27d44c\" href=\"https:\/\/flcube.com\/wp-content\/uploads\/2026\/05\/sehk26051500133_c.pdf\">sehk26051500133_c<\/a><a href=\"https:\/\/flcube.com\/wp-content\/uploads\/2026\/05\/sehk26051500133_c.pdf\" class=\"wp-block-file__button wp-element-button\" download aria-describedby=\"wp-block-file--media-124fa096-2a2d-4952-ad68-32dc6b27d44c\">Download<\/a><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Shandong Ande Healthcare Apparatus Co., Ltd. has released its prospectus and formally applied for listing&#8230;<\/p>\n","protected":false},"author":1,"featured_media":65666,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"googlesitekit_rrm_CAownpewDA:productID":"","_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[7,10],"tags":[4744,72],"class_list":["post-65663","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-company","category-deals","tag-ande-healthcare-apparatus","tag-ipo"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v27.5 (Yoast SEO v27.6) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Ande Healthcare Files Hong Kong IPO Prospectus as Leading Chinese Medical Consumables Innovator - Insight, China&#039;s Pharmaceutical Industry<\/title>\n<meta name=\"description\" content=\"Shandong Ande Healthcare Apparatus Co., Ltd. has released its prospectus and formally applied for listing on the Hong Kong Stock Exchange, marking a significant milestone for one of China&#039;s leading innovative medical consumables providers. The company offers a competitive and diversified product portfolio spanning critical healthcare segments including drug delivery, vascular access, blood specimen collection, and specialized categories encompassing interventional therapy products, surgical products, and medical imaging consumables.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/flcube.com\/?p=65663\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Ande Healthcare Files Hong Kong IPO Prospectus as Leading Chinese Medical Consumables Innovator\" \/>\n<meta property=\"og:description\" content=\"Shandong Ande Healthcare Apparatus Co., Ltd. has released its prospectus and formally applied for listing on the Hong Kong Stock Exchange, marking a significant milestone for one of China&#039;s leading innovative medical consumables providers. The company offers a competitive and diversified product portfolio spanning critical healthcare segments including drug delivery, vascular access, blood specimen collection, and specialized categories encompassing interventional therapy products, surgical products, and medical imaging consumables.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/flcube.com\/?p=65663\" \/>\n<meta property=\"og:site_name\" content=\"Insight, China&#039;s Pharmaceutical Industry\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/profile.php?id=61566606313834\" \/>\n<meta property=\"article:published_time\" content=\"2026-05-19T11:55:36+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-05-19T11:55:37+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/flcube.com\/wp-content\/uploads\/2026\/05\/1903.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"1080\" \/>\n\t<meta property=\"og:image:height\" content=\"608\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Fineline Cube\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:description\" content=\"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Fineline Cube\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=65663#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=65663\"},\"author\":{\"name\":\"Fineline Cube\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\"},\"headline\":\"Ande Healthcare Files Hong Kong IPO Prospectus as Leading Chinese Medical Consumables Innovator\",\"datePublished\":\"2026-05-19T11:55:36+00:00\",\"dateModified\":\"2026-05-19T11:55:37+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=65663\"},\"wordCount\":508,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=65663#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2026\\\/05\\\/1903.webp\",\"keywords\":[\"Ande Healthcare Apparatus\",\"IPO\"],\"articleSection\":[\"Company\",\"Deals\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=65663#respond\"]}],\"copyrightYear\":\"2026\",\"copyrightHolder\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=65663\",\"url\":\"https:\\\/\\\/flcube.com\\\/?p=65663\",\"name\":\"Ande Healthcare Files Hong Kong IPO Prospectus as Leading Chinese Medical Consumables Innovator - Insight, China&#039;s Pharmaceutical Industry\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=65663#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=65663#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2026\\\/05\\\/1903.webp\",\"datePublished\":\"2026-05-19T11:55:36+00:00\",\"dateModified\":\"2026-05-19T11:55:37+00:00\",\"description\":\"Shandong Ande Healthcare Apparatus Co., Ltd. has released its prospectus and formally applied for listing on the Hong Kong Stock Exchange, marking a significant milestone for one of China's leading innovative medical consumables providers. The company offers a competitive and diversified product portfolio spanning critical healthcare segments including drug delivery, vascular access, blood specimen collection, and specialized categories encompassing interventional therapy products, surgical products, and medical imaging consumables.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=65663#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=65663\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=65663#primaryimage\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2026\\\/05\\\/1903.webp\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2026\\\/05\\\/1903.webp\",\"width\":1080,\"height\":608,\"caption\":\"Ande Healthcare Files Hong Kong IPO Prospectus as Leading Chinese Medical Consumables Innovator\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=65663#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/flcube.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Ande Healthcare Files Hong Kong IPO Prospectus as Leading Chinese Medical Consumables Innovator\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"name\":\"Insight, China's Pharmaceutical Industry\",\"description\":\"Fineline Insights, Pharma Clarity\",\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/flcube.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\",\"name\":\"Fineline Infomation and Technology\",\"alternateName\":\"Fineline Info & Tech\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"width\":2560,\"height\":1894,\"caption\":\"Fineline Infomation and Technology\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/profile.php?id=61566606313834\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\",\"name\":\"Fineline Cube\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"caption\":\"Fineline Cube\"},\"sameAs\":[\"https:\\\/\\\/flcube.com\"],\"url\":\"https:\\\/\\\/flcube.com\\\/?author=1\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Ande Healthcare Files Hong Kong IPO Prospectus as Leading Chinese Medical Consumables Innovator - Insight, China&#039;s Pharmaceutical Industry","description":"Shandong Ande Healthcare Apparatus Co., Ltd. has released its prospectus and formally applied for listing on the Hong Kong Stock Exchange, marking a significant milestone for one of China's leading innovative medical consumables providers. The company offers a competitive and diversified product portfolio spanning critical healthcare segments including drug delivery, vascular access, blood specimen collection, and specialized categories encompassing interventional therapy products, surgical products, and medical imaging consumables.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/flcube.com\/?p=65663","og_locale":"en_US","og_type":"article","og_title":"Ande Healthcare Files Hong Kong IPO Prospectus as Leading Chinese Medical Consumables Innovator","og_description":"Shandong Ande Healthcare Apparatus Co., Ltd. has released its prospectus and formally applied for listing on the Hong Kong Stock Exchange, marking a significant milestone for one of China's leading innovative medical consumables providers. The company offers a competitive and diversified product portfolio spanning critical healthcare segments including drug delivery, vascular access, blood specimen collection, and specialized categories encompassing interventional therapy products, surgical products, and medical imaging consumables.","og_url":"https:\/\/flcube.com\/?p=65663","og_site_name":"Insight, China&#039;s Pharmaceutical Industry","article_publisher":"https:\/\/www.facebook.com\/profile.php?id=61566606313834","article_published_time":"2026-05-19T11:55:36+00:00","article_modified_time":"2026-05-19T11:55:37+00:00","og_image":[{"width":1080,"height":608,"url":"https:\/\/flcube.com\/wp-content\/uploads\/2026\/05\/1903.webp","type":"image\/png"}],"author":"Fineline Cube","twitter_card":"summary_large_image","twitter_description":"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM","twitter_misc":{"Written by":"Fineline Cube","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/flcube.com\/?p=65663#article","isPartOf":{"@id":"https:\/\/flcube.com\/?p=65663"},"author":{"name":"Fineline Cube","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a"},"headline":"Ande Healthcare Files Hong Kong IPO Prospectus as Leading Chinese Medical Consumables Innovator","datePublished":"2026-05-19T11:55:36+00:00","dateModified":"2026-05-19T11:55:37+00:00","mainEntityOfPage":{"@id":"https:\/\/flcube.com\/?p=65663"},"wordCount":508,"commentCount":0,"publisher":{"@id":"https:\/\/flcube.com\/#organization"},"image":{"@id":"https:\/\/flcube.com\/?p=65663#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2026\/05\/1903.webp","keywords":["Ande Healthcare Apparatus","IPO"],"articleSection":["Company","Deals"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/flcube.com\/?p=65663#respond"]}],"copyrightYear":"2026","copyrightHolder":{"@id":"https:\/\/flcube.com\/#organization"}},{"@type":"WebPage","@id":"https:\/\/flcube.com\/?p=65663","url":"https:\/\/flcube.com\/?p=65663","name":"Ande Healthcare Files Hong Kong IPO Prospectus as Leading Chinese Medical Consumables Innovator - Insight, China&#039;s Pharmaceutical Industry","isPartOf":{"@id":"https:\/\/flcube.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/flcube.com\/?p=65663#primaryimage"},"image":{"@id":"https:\/\/flcube.com\/?p=65663#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2026\/05\/1903.webp","datePublished":"2026-05-19T11:55:36+00:00","dateModified":"2026-05-19T11:55:37+00:00","description":"Shandong Ande Healthcare Apparatus Co., Ltd. has released its prospectus and formally applied for listing on the Hong Kong Stock Exchange, marking a significant milestone for one of China's leading innovative medical consumables providers. The company offers a competitive and diversified product portfolio spanning critical healthcare segments including drug delivery, vascular access, blood specimen collection, and specialized categories encompassing interventional therapy products, surgical products, and medical imaging consumables.","breadcrumb":{"@id":"https:\/\/flcube.com\/?p=65663#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/flcube.com\/?p=65663"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/?p=65663#primaryimage","url":"https:\/\/flcube.com\/wp-content\/uploads\/2026\/05\/1903.webp","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2026\/05\/1903.webp","width":1080,"height":608,"caption":"Ande Healthcare Files Hong Kong IPO Prospectus as Leading Chinese Medical Consumables Innovator"},{"@type":"BreadcrumbList","@id":"https:\/\/flcube.com\/?p=65663#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/flcube.com\/"},{"@type":"ListItem","position":2,"name":"Ande Healthcare Files Hong Kong IPO Prospectus as Leading Chinese Medical Consumables Innovator"}]},{"@type":"WebSite","@id":"https:\/\/flcube.com\/#website","url":"https:\/\/flcube.com\/","name":"Insight, China's Pharmaceutical Industry","description":"Fineline Insights, Pharma Clarity","publisher":{"@id":"https:\/\/flcube.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/flcube.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/flcube.com\/#organization","name":"Fineline Infomation and Technology","alternateName":"Fineline Info & Tech","url":"https:\/\/flcube.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/","url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","width":2560,"height":1894,"caption":"Fineline Infomation and Technology"},"image":{"@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/profile.php?id=61566606313834"]},{"@type":"Person","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a","name":"Fineline Cube","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","caption":"Fineline Cube"},"sameAs":["https:\/\/flcube.com"],"url":"https:\/\/flcube.com\/?author=1"}]}},"jetpack_publicize_connections":[],"jetpack_featured_media_url":"https:\/\/flcube.com\/wp-content\/uploads\/2026\/05\/1903.webp","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/65663","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=65663"}],"version-history":[{"count":1,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/65663\/revisions"}],"predecessor-version":[{"id":65667,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/65663\/revisions\/65667"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/media\/65666"}],"wp:attachment":[{"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=65663"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=65663"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=65663"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}